OTC Tramadol Sales By 21 Online Pharmacies Found In US FDA Sweep
This article was originally published in The Pink Sheet & The Rose Sheet
Executive Summary
FDA warns four online pharmacies associated with websites selling opioid products without prescriptions and advises more crack-downs are on horizon. Products identified in the warnings, formulated with tramadol, and other drugs sold on the websites are misbranded and unapproved new drugs.
You may also be interested in...
Opioid Drug Sales Online Draw US FDA Warnings, Prompt Summit Meeting
At June 27 "Online Opioid Summit," FDA officials, pharma sales researchers, and industry stakeholders will discuss collaborating for stronger impact against the opioid crisis by reducing the availability of illicit products online."The internet is virtually awash in illegal narcotics and we’re going to be taking new steps to work with legitimate internet firms to voluntarily crack down on these sales," says Commissioner Scott Gottlieb.
Drug Abuse Withdrawal Supplement Marketers Warned, Claims And Sales Continue
FDA and FTC send joint warning letters to 11 US firms about 12 products marketed as unapproved drugs with claims about aiding in the treatment of opioid addiction and withdrawal. FDA also thanks CSPI for suggesting the agencies investigate a scourge of fraudulent drug-abuse withdrawal claims.
Cosmetics Industry Awaits FDA’s Allergen List While Working To Inform GMP Rulemaking
The Independent Beauty Association does not yet have insight into what ingredients will be listed in the US FDA’s proposed rulemaking for cosmetic allergen labeling – due by 29 June – but is optimistic the agency will consult industry when it comes to setting the compliance timeline. Meanwhile, industry stakeholders are pushing for international harmonization in the agency’s cosmetic GMPs rulemaking.